Chuck Royce's MD Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 678,770 shares of Pediatrix Medical Group, Inc. (MD) worth $14.52 M, representing 0.14% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in MD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 424,022 shares. Largest reduction occurred in Q3 2013, reducing 579,138 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Pediatrix Medical Group (MD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pediatrix Medical Group (MD) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +424,022 | Add 166.45% | 678,770 | $21.39 |
| Q4 2025 | +75,702 | Add 42.28% | 254,748 | $21.39 |
| Q3 2025 | -17,074 | Reduce 8.71% | 179,046 | $16.75 |
| Q2 2025 | -5,511 | Reduce 2.73% | 196,120 | $14.35 |
| Q1 2025 | -4,452 | Reduce 2.16% | 201,631 | $14.49 |
| Q4 2024 | +8,711 | Add 4.41% | 206,083 | $13.12 |
| Q3 2024 | +31,482 | Add 18.98% | 197,372 | $11.59 |
| Q2 2024 | +14,506 | Add 9.58% | 165,890 | $7.55 |
| Q1 2024 | +21,485 | Add 16.54% | 151,384 | $10.03 |
| Q4 2023 | +49,137 | Add 60.84% | 129,899 | $9.30 |
| Q3 2023 | +38,172 | Add 89.63% | 80,762 | $12.71 |
| Q2 2023 | +42,590 | New Buy | 42,590 | $14.21 |
| Q2 2022 | -11,057 | Sold Out | 0 | $0.00 |
| Q1 2022 | -17,985 | Reduce 61.93% | 11,057 | $23.51 |
| Q4 2021 | -4,757 | Reduce 14.07% | 29,042 | $27.20 |
| Q3 2021 | +13,293 | Add 64.82% | 33,799 | $28.43 |
| Q2 2021 | -699 | Reduce 3.30% | 20,506 | $30.14 |
| Q1 2021 | +21,205 | New Buy | 21,205 | $25.47 |
| Q3 2020 | -3,441 | Sold Out | 0 | $0.00 |
| Q2 2020 | -517 | Reduce 13.06% | 3,441 | $17.15 |
| Q1 2020 | +1,161 | Add 41.51% | 3,958 | $11.62 |
| Q4 2019 | -580 | Reduce 17.18% | 2,797 | $27.89 |
| Q3 2019 | +3,377 | New Buy | 3,377 | $22.51 |
| Q1 2016 | -11,662 | Sold Out | 0 | $0.00 |
| Q4 2015 | -77,082 | Reduce 86.86% | 11,662 | $71.69 |
| Q3 2015 | -298,289 | Reduce 77.07% | 88,744 | $76.79 |
| Q2 2015 | -19,400 | Reduce 4.77% | 387,033 | $74.11 |
| Q1 2015 | -129,235 | Reduce 24.13% | 406,433 | $72.51 |
| Q4 2014 | -351,846 | Reduce 39.64% | 535,668 | $66.11 |
| Q3 2014 | +3,800 | Add 0.43% | 887,514 | $54.82 |
| Q2 2014 | -131,400 | Reduce 12.94% | 883,714 | $58.15 |
| Q1 2014 | -52,300 | Reduce 4.90% | 1.02 M | $61.98 |
| Q4 2013 | -446,600 | Reduce 29.50% | 1.07 M | $53.38 |
| Q3 2013 | -579,138 | Reduce 27.67% | 1.51 M | $50.20 |
| Q2 2013 | +2.09 M | Add 0.00% | 2.09 M | $45.79 |
Chuck Royce's Pediatrix Medical Group Investment FAQs
Chuck Royce first purchased Pediatrix Medical Group, Inc. (MD) in Q2 2013, acquiring 2,093,152 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Pediatrix Medical Group, Inc. (MD) for 35 quarters since Q2 2013.
Chuck Royce's largest addition to Pediatrix Medical Group, Inc. (MD) was in Q2 2013, adding 2,093,152 shares worth $95.84 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 678,770 shares of Pediatrix Medical Group, Inc. (MD), valued at approximately $14.52 M.
As of the Q1 2026 filing, Pediatrix Medical Group, Inc. (MD) represents approximately 0.14% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Pediatrix Medical Group, Inc. (MD) was 2,093,152 shares, as reported at the end of Q2 2013.